Assessment of real life kinetics of new HBV markers on chronically infected hepatitis D virus (HDV) RNA positive adult patients treated with this recently approved treatment
Latest Information Update: 18 Aug 2021
At a glance
- Drugs Bulevirtide (Primary) ; Peginterferon alfa (Primary)
- Indications Hepatitis D
- Focus Pharmacodynamics
- 18 Aug 2021 New trial record
- 26 Jun 2021 Results presented at The International Liver Congress 2021